These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24839216)

  • 21. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
    Marshall H; Nolan T; Díez Domingo J; Rombo L; Sokal EM; Marès J; Casanovas JM; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Jun; 28(27):4411-5. PubMed ID: 20434544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.
    Cunningham CK; Rudy BJ; Xu J; Bethel J; Kapogiannis BG; Ahmad S; Wilson CM; Flynn PM;
    Pediatr Infect Dis J; 2010 Jun; 29(6):530-4. PubMed ID: 20173677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
    Cardell K; Akerlind B; Sällberg M; Frydén A
    J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
    Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
    Van Der Wielen M; Van Damme P; Collard F
    Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Beran J; Van Der Meeren O; Leyssen M; D'silva P
    Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroconversion following hepatitis B vaccination in children with chronic kidney disease.
    Kamath N; Vasudevan A; Iyengar A
    Saudi J Kidney Dis Transpl; 2019; 30(2):334-338. PubMed ID: 31031369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis.
    Schönberger K; Riedel C; Rückinger S; Mansmann U; Jilg W; Kries RV
    Pediatr Infect Dis J; 2013 Apr; 32(4):307-13. PubMed ID: 23249904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N
    Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.
    Giambi C; Bella A; Barale A; Montù D; Marchisio M; Oddone M; Zito S; Rapicetta M; Chionne P; Madonna E; Ciofi degli Atti ML
    BMC Infect Dis; 2008 Jul; 8():100. PubMed ID: 18662386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.